Qube Research & Technologies (QRT)’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-177,693
Closed -$1.09M 3777
2025
Q3
$1.09M Sell
177,693
-548,505
-76% -$4.28M ﹤0.01% 2474
2025
Q2
$6.69M Sell
726,198
-55,350
-7% -$566K 0.01% 1532
2025
Q1
$9.4M Buy
781,548
+27,469
+4% +$359K 0.01% 1178
2024
Q4
$8.33M Buy
754,079
+187,031
+33% +$2.63M 0.01% 1204
2024
Q3
$9.19M Buy
567,048
+40,431
+8% +$565K 0.01% 1090
2024
Q2
$5.71M Buy
526,617
+258,672
+97% +$3.18M 0.01% 1199
2024
Q1
$3.75M Buy
267,945
+221,853
+481% +$2.88M 0.01% 1395
2023
Q4
$485K Buy
46,092
+36,260
+369% +$324K ﹤0.01% 2305
2023
Q3
$89.9K Sell
9,832
-1,165
-11% -$10.4K ﹤0.01% 2684
2023
Q2
$79.9K Buy
+10,997
New +$94.9K ﹤0.01% 1993
2022
Q4
Sell
-16,982
Closed -$137K 2599
2022
Q3
$137K Buy
+16,982
New +$180K ﹤0.01% 1880
2021
Q4
Sell
-44,207
Closed -$337K 2635
2021
Q3
$337K Buy
44,207
+30,600
+225% +$316K ﹤0.01% 1435
2021
Q2
$172K Buy
+13,607
New +$150K ﹤0.01% 1834

Other funds holding EOLS

Qube Research & Technologies (QRT)'s EOLS Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Evolus (EOLS) in Q4 2025, closing a stake of 177,693 shares — an estimated $1.09M sold.

Qube Research & Technologies (QRT) first reported a position in EOLS in Q2 2021 and held it in 13 quarters. The position peaked at $9.4M in Q1 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 177,693 Evolus shares in Q4 2025, an estimated $1.09M.
  • Qube Research & Technologies (QRT) first reported a position in Evolus in Q2 2021 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Evolus position peaked at $9.4M in Q1 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.